[HTML][HTML] Neuropathology of Alzheimer's disease

JA Trejo-Lopez, AT Yachnis, S Prokop - Neurotherapeutics, 2022 - Elsevier
The key pathological hallmarks—extracellular plaques and intracellular neurofibrillary
tangles (NFT)—described by Alois Alzheimer in his seminal 1907 article are still central to …

Brain lipidomics: From functional landscape to clinical significance

JH Yoon, Y Seo, YS Jo, S Lee, E Cho… - Science …, 2022 - science.org
Lipids are crucial components of cellular function owing to their role in membrane formation,
intercellular signaling, energy storage, and homeostasis maintenance. In the brain, lipid …

[HTML][HTML] The foundation and architecture of precision medicine in neurology and psychiatry

H Hampel, P Gao, J Cummings, N Toschi… - Trends in …, 2023 - cell.com
Neurological and psychiatric diseases have high degrees of genetic and pathophysiological
heterogeneity, irrespective of clinical manifestations. Traditional medical paradigms have …

Applications of multi‐omics analysis in human diseases

C Chen, J Wang, D Pan, X Wang, Y Xu, J Yan… - MedComm, 2023 - Wiley Online Library
Multi‐omics usually refers to the crossover application of multiple high‐throughput screening
technologies represented by genomics, transcriptomics, single‐cell transcriptomics …

A global view of the genetic basis of Alzheimer disease

C Reitz, MA Pericak-Vance, T Foroud… - Nature Reviews …, 2023 - nature.com
The risk of Alzheimer disease (AD) increases with age, family history and informative genetic
variants. Sadly, there is still no cure or means of prevention. As in other complex diseases …

Survey on multi-omics, and multi-omics data analysis, integration and application

MH Shahrajabian, W Sun - Current Pharmaceutical Analysis, 2023 - benthamdirect.com
Multi-omics approaches have developed as a profitable technique for plant systems, a
popular method in medical and biological sciences underlining the necessity to outline new …

Artificial intelligence for Alzheimer's disease: promise or challenge?

C Fabrizio, A Termine, C Caltagirone, G Sancesario - Diagnostics, 2021 - mdpi.com
Decades of experimental and clinical research have contributed to unraveling many
mechanisms in the pathogenesis of Alzheimer's disease (AD), but the puzzle is still …

Transgenic mouse models of Alzheimer's disease: An integrative analysis

R Sanchez-Varo, M Mejias-Ortega… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) constitutes the most prominent form of dementia among elderly
individuals worldwide. Disease modeling using murine transgenic mice was first initiated …

Epigenetics in Alzheimer's disease

X Gao, Q Chen, H Yao, J Tan, Z Liu, Y Zhou… - Frontiers in aging …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disease with unknown pathogenesis and
complex pathological manifestations. At present, a large number of studies on targeted …

Linking the amyloid, tau, and mitochondrial hypotheses of Alzheimer's disease and identifying promising drug targets

Z Fišar - Biomolecules, 2022 - mdpi.com
Damage or loss of brain cells and impaired neurochemistry, neurogenesis, and synaptic and
nonsynaptic plasticity of the brain lead to dementia in neurodegenerative diseases, such as …